TANG CAPITAL MANAGEMENT LLC Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$355.4B
Holdings
11
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (11 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTROCKET PHARMACEUTICALS INC | 2,531,800 | $112.3B | 31.61% | |
| 2 | ANABANAPTYSBIO INC | 2,628,678 | $56.6B | 15.94% | |
| 3 | APVOAPTEVO THERAPEUTICS INC | 1,760,000 | $53.7B | 15.11% | |
| 4 | —ODONATE THERAPEUTICS INC | 15,514,566 | $53.1B | 14.93% | |
| 5 | —LA JOLLA PHARMACEUTICAL CO | 9,405,490 | $39.9B | 11.22% | |
| 6 | —VINCERX PHARMA INC | 500,000 | $9.7B | 2.72% | |
| 7 | CHRSCOHERUS BIOSCIENCES INC | 650,000 | $9.5B | 2.67% | |
| 8 | RLMDRELMADA THERAPEUTICS INC | 200,000 | $7.0B | 1.98% | |
| 9 | —BCTG ACQUISITION CORP | 468,750 | $5.2B | 1.47% | |
| 10 | EQEQUILLIUM INC | 600,000 | $4.3B | 1.21% | |
| 11 | —VINCERX PHARMA INC | 1,014,368 | $4.1B | 1.15% |